Mild hypercholesterolemia blunts the proinflammatory and prothrombotic effects of hypertension on the cerebral microcirculation

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 4, 2013, Pages 483-489

  Rodrigues, Stephen F ^a   Vital, Shantel A ^a   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

cerebral microvasculature; HDL cholesterol; hypercholesterolemia; hypertension; inflammation

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; BRAIN CIRCULATION; CONTROLLED STUDY; DISEASE SEVERITY; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; LEUKOCYTE ADHERENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ADHESION; VENULE; WILD TYPE;

ANGIOTENSIN II; ANIMALS; APOLIPOPROTEIN A-I; BLOOD-BRAIN BARRIER; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPOPROTEINS, HDL; MALE; MICE; MICE, TRANSGENIC; MICROCIRCULATION; VASOCONSTRICTOR AGENTS; VENULES;

EID: 84876420536     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.194     Document Type: Article

References (41)

1. Berni A, Ciani E, Bernetti M, Cecioni I, Berardino S, Poggesi L et al. Renal resistive index and low-grade inflammation in patients with essential hypertension. J Hum Hypertens 2012; 26: 723-730.
2. Chamarthi B, Williams GH, Ricchiuti V, Srikumar N, Hopkins PN, Luther JM et al. Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens 2011; 24: 1143-1148.
3. Stumpf C, Auer C, Yilmaz A, Lewczuk P, Klinghammer L, Schneider M et al. Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension. Hypertens Res 2011; 34: 484-488.
4. Espinoza M, Ruiz N, Leal U, Urbaneja H, Rojas S, Orozco U et al. C-reactive protein is associated to carotid intima media thickness in patients with isolated hypercholesterolemia. Invest Clin 2010; 51: 65-75.
5. Real JT, Martínez-Hervás S, García-García AB, Civera M, Pallardó FV, Ascaso JF et al. Circulating mononuclear cells nuclear factor-kappa B activity, plasma xanthine oxidase, and low grade inflammatory markers in adult patients with familial hypercholesterolaemia. Eur J Clin Invest 2010; 40: 89-94.
6. Yang Z, Zhang Z, Wen J, Wang X, Lu B, Yang Z et al. Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people. J Clin Endocrinol Metab 2010; 95: 3926-3932.
7. Ishikawa M, Stokes KY, Zhang JH, Nanda A, Granger DN. Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin. Circ Res 2004; 94: 239-244.
8. Rodrigues SF, Granger DN. Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide. J Cereb Blood Flow Metab 2012; 32: 368-375.
9. Vital SA, Terao S, Nagai M, Granger DN. Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation 2010; 17: 641-649.
10. Zhang M, Mao Y, Ramirez SH, Tuma RF, Chabrashvili T. Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 2010; 171: 852-858.
11. De Bacquer D, De Backer G. The prevalence of concomitant hypertension and hypercholesterolaemia in the general population. Int J Cardiol 2006; 110: 217-223.
12. Smith GD, Pekkanen J. The cholesterol controversy. BMJ 1992; 304: 913.
13. Rodriguez-Porcel M, Lerman A, Herrmann J, Schwartz RS, Sawamura T, Condorelli M et al. Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res 2003; 58: 213-221.
14. Chobanian AV, Lichtenstein AH, Nilakhe V, Haudenschild CC, Drago R, Nickerson C. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension 1989; 14: 203-209.
15. Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL et al. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J 2011; 25: 290-300.
16. Ishikawa M, Vowinkel T, Stokes KY, Arumugam TV, Yilmaz G, Nanda A et al. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 2005; 111: 1690-1696.
17. Ishikawa M, Sekizuka E, Yamaguchi N, Nakadate H, Terao S, Granger DN et al. Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte- endo-thelial cell interactions in the cerebral microvasculature. Am J Physiol Heart Circ Physiol 2007; 292: H2306-H2315.
18. Russell J, Cooper D, Tailor A, Stokes KY, Granger DN. Low venular shear rates promote leukocyte-dependent recruitment of adherent platelets. Am J Physiol Gastrointest Liver Physiol 2003; 284: G123-G129.
19. Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 1988; 8: 282-284.
20. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Measuring the global burden of disease and risk factors, 1990-2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (eds). Global Burden of Disease and Risk Factors. World Bank: Washington, DC, 2006, Chapter 1.
21. Javeshghani D, Schiffrin EL, Sairam MR, Touyz RM. Potentiation of vascular oxi-dative stress and nitric oxide-mediated endothelial dysfunction by high-fat diet in a mouse model of estrogen deficiency and hyperandrogenemia. J Am Soc Hypertens 2009; 3: 295-305.
22. Arruda RM, Peotta VA, Meyrelles SS, Vasquez EC. Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Hypertension 2005; 46: 932-936.
23. Lorkowska B, Bartus M, Franczyk M, Kostogrys RB, Jawien J, Pisulewski PM et al. Hypercholesterolemia does not alter endothelial function in spontaneously hypertensive rats. J Pharmacol Exp Ther 2006; 317: 1019-1026.
24. Cappelli-Bigazzi M, Rubattu S, Battaglia C, Russo R, Enea I, Ambrosio G et al. Effects of high-cholesterol and atherogenic diets on vascular relaxation in spontaneously hypertensive rats. Am J Physiol 1997; 273: H647-H654.
25. Desai MS, Mariscalco MM, Tawil A, Vallejo JG, Smith CW. Atherogenic diet-induced hepatitis is partially dependent on murine TLR4. J Leukoc Biol 2008; 83: 1336-1344.
26. Vergnes L, Phan J, Strauss M, Tafuri S, Reue K. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem 2003; 278: 42774-42784.
27. Samokhin AO, Bühling F, Theissig F, Brömme D. ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis. Am J Pathol 2010; 176: 1148-1156.
28. -/~ mice. Arterioscler Thromb Vasc Biol 2010; 30: 1166-1173.
29. Fleegal-DeMotta MA, Doghu S, Banks WA. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab 2009; 29: 640-647.
30. Hayek T, Ito Y, Azrolan N, Verdery RB, Aalto-Setälä K, Walsh A et al. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice. J Clin Invest 1993; 91: 1665-1671.
31. Dimayuga P, Zhu J, Oguchi S, Chyu KY, Xu XO, Yano J et al. Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice. Biochem Biophys Res Commun 1999; 264: 465-468.
32. Lapergue B, Moreno JA, Dang BQ, Coutard M, Delbosc S, Raphaeli G et al. Protective effect of high-density lipoprotein-based therapy in a model of embolic stroke. Stroke 2010; 41: 1536-1542.
33. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC et al. Shotgun proteomics implicates protease inhibition and complement activation in the anti-inflammatory properties of HDL. J Clin Invest 2007; 117: 746-756.
34. Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L et al. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 2003; 107: 2726-2732.
35. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 1991; 353: 265-267.
36. Buga GM, Navab M, Imaizumi S, Reddy ST, Yekta B, Hough G et al. L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation. Arterioscler Thromb Vasc Biol 2010; 30: 283-289.
37. Zhang Z, Datta G, Zhang Y, Miller AP, Mochon P, Chen YF et al. Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. Am J Physiol Heart Circ Physiol 2009; 297: H866-H873.
38. Murphy AJ, Woollard KJ, Suhartoyo A, Stirzaker RA, Shaw J, Sviridov D et al. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol 2011; 31: 1333-1341.
39. Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol 2010; 37: 710-718.
40. Besler C, Lüscher TF, Landmesser U. Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease. EMBO Mol Med 2012; 4: 251-268.
41. Nofer JR, Brodde MF, Kehrel BE. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis. Clin Exp Pharmacol Physiol 2010; 37: 726-735.